Phase 2 Clinical Trials

Phase 2 clinical trials test a new treatment on a larger group of people to assess its effectiveness and safety. This phase involves hundreds of participants who have the condition the treatment aims to address. Researchers evaluate how well the treatment works, identify side effects, and determine optimal dosages. The goal is to gather enough information to decide if the treatment is promising enough to move forward to larger, more definitive studies in Phase 3. These trials are essential for ensuring that new medicines or therapies are both safe and effective before widespread use.